DYN vs TNGX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DYN · Dyne Therapeutics$18.07 ▲ 4.09%
TNGX · Tango Therapeutics$21.50 ▲ 3.02%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DYN -2.4%
- TNGX +171.1%
Head to head
| Metric | DYN | TNGX |
|---|---|---|
| Price | $18.07 | $21.50 |
| Change today | ▲ 4.09% | ▲ 3.02% |
| Market cap | $3.39B | $3.63B |
| Return, 3 months | -31.8% | -22.3% |
| Return, year to date | -7.6% | +142.7% |
| Return, 1 year | -1.6% | +173.2% |
| P/E (TTM) | – | – |
| P/B | 3.6 | 3.5 |
| P/E percentile vs own 5y | 33rd | 8th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -100.0% |
| Net profit growth (YoY) | -61.1% | -42.4% |
| Gross margin | – | – |
| Operating margin | – | -253.4% |
| Net margin | – | -229.9% |
| Return on equity | -81.6% | -21.3% |
| Analyst target vs. price | +90.9% | +120.9% |
| Analyst buy share | 90% | 100% |
| RSI (14) | 57 | 44 |
| 30-day volatility | 57.9% | 87.6% |
| Max drawdown, 1 year | -46.8% | -36.6% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TNGX is the largest of the group by market value.
- TNGX has returned the most over the past year.
- DYN has been the calmest stock over the last 30 days.